Gene content    
IRF1 ( by HUGO)
Interferon Regulatory Factor 1
Tumor suppressor gene
Interferon Regulatory Factor 1
IRF-1
MAR
Interferon Regulatory Factor-1
Interferon Regulatory Factor 1 Isoform D78
NCBI: 5q31.1    Ensembl: 5q31.1
IRF1_HUMANSize: 325 amino acidsMass: 36502 Da

  • Subunit: Monomer. Homodimer. Interacts with MYD88 and PIAS3 (By similarity). Interacts with EP300 Miscellaneous: Deletion or rearrangement of IRF1 are found in preleukemic myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML)
  • Function:
    UniProtKB/Swiss-Prot Summary: IRF1_HUMAN, P10914 Function: Transcriptional regulator which displays a remarkable functional diversity in the regulation of cellular responses. These include the regulation of IFN and IFN-inducible genes, host response to viral and bacterial infections, regulation of many genes expressed during hematopoiesis, inflammation, immune responses and cell proliferation and differentiation, regulation of the cell cycle and induction of growth arrest and programmed cell death following DNA damage. Stimulates both innate and acquired immune responses through the activation of specific target genes and can act as a transcriptional activator and repressor regulating target genes by binding to an interferon-stimulated response element (ISRE) in their promoters. Its target genes for transcriptional activation activity include: genes involved in anti-viral response, such as IFN-alpha/beta, DDX58/RIG-I, TNFSF10/TRAIL, OAS1/2, PIAS1/GBP, EIF2AK2/PKR and RSAD2/viperin; antibacterial response, such as NOS2/INOS; anti-proliferative response, such as p53/TP53, LOX and CDKN1A; apoptosis, such as BBC3/PUMA, CASP1, CASP7 and CASP8; immune response, such as IL7, IL12A/B and IL15, PTGS2/COX2 and CYBB; DNA damage responses and DNA repair, such as POLQ/POLH; MHC class I expression, such as TAP1, PSMB9/LMP2, PSME1/PA28A, PSME2/PA28B and B2M and MHC class II expression, such as CIITA. Represses genes involved in anti-proliferative response, such as BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2 and CDK4 and in immune response, such as FOXP3, IL4, ANXA2 and TLR4. Stimulates p53/TP53-dependent transcription through enhanced recruitment of EP300 leading to increased acetylation of p53/TP53. Plays an important role in immune response directly affecting NK maturation and activity, macrophage production of IL12, Th1 development and maturation of CD8+ T-cells. Also implicated in the differentiation and maturation of dendritic cells and in the suppression of regulatory T (Treg) cells development. Acts as a tumor suppressor and plays a role not only in antagonism of tumor cell growth but also in stimulating an immune response against tumor cells Enzyme regulation: Activated by MYD88 (By similarity)
  • Similarity:
    Belongs to the IRF family
                          
    Contains 1 IRF tryptophan pentad repeat DNA-binding domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR001346Interferon_reg_fact_DNA-bd_domInterferon regulatory factorDomain
    IPR011991WHTH_DNA-bd_domWinged helix repressor DNA-bindingDomain
    BlocksIPB001346Interferon regulatory factorInterferon regulatory factor

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process apoptotic process IDA GOA 19851330
    cellular response to interferon-beta IDA GOA 18035482
    cellular response to mechanical stimulus IEP GOA 19593445
    negative regulation of cell proliferation TAS GOA 11846974
    negative regulation of transcription, DNA-templated IMP GOA 18084608
    positive regulation of transcription, DNA-templated IMP GOA 15509808
    regulation of adaptive immune response TAS GOA 11846971
    regulation of cell cycle TAS GOA 11846974
    regulation of innate immune response TAS GOA 11846971
    transcription from RNA polymerase II promoter TAS GOA 2475256
    Cellular Component nuclear chromatin IDA GOA 18035482
    nucleus TAS GOA 11846971
    Molecular Function DNA binding TAS GOA 11846971
    protein binding IPI GOA 10702232
    RNA polymerase II core promoter proximal region sequence-specific DNA binding IDA GOA 18035482

    Disorder & Mutation    
    Source Disease
    SWISS-PROTGastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The disease is caused by mutations affecting the gene represented in this entry

    IRF1 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene